Masp-2 and masp-3 inhibitors, and related compositions and methods, for treatment of sickle cell disease

ZA202608333APending Publication Date: 2026-08-26OMEROS CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ZA202608333
Authority / Receiving Office
ZA · ZA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-03-10
Filing Date
2026-08-19
Publication Date
2026-08-26
Patent Text Reader

Abstract

NOT VISIBLE DUE TO STATUS OF PATENT
Need to check novelty before this filing date? Find Prior Art